A pyrazolo[1,5-a]pyridine derivative represented by formula (I) and salt thereof exhibit excellent MAPKAP-K2 inhibitory activity. Accordingly, medicines comprising this compound as an active ingredient are expected to be valuable for treating or preventing diseases mediated by MAPKAP-K2 such as inflammatory injury, autoimmune diseases, asteropathia destruens, cancer and/or growth of tumor. ##STR00001##

 
Web www.patentalert.com

< Fused tricyclic compounds as inhibitors of 17.beta.-hydroxysteroid dehydrogenase 3

> Naphthyridine compounds

~ 00457